Search Results for 'amputations'

Parkmore-based VERSONO® Medical Ltd has begun enrolling patients in the FREEFLOW pivotal study for its FastWire System. FastWire is a truly disruptive technology designed to quickly access previously untreatable complex blockages in arteries, increasing success rates and reducing risk of amputations via endovascular techniques.

Parkmore-based VERSONO® Medical Ltd has begun enrolling patients in the FREEFLOW pivotal study for its FastWire System. FastWire is a truly disruptive technology designed to quickly access previously untreatable complex blockages in arteries, increasing success rates and reducing risk of amputations via endovascular techniques.

Did you know that Ireland is currently one of the top spenders in the world on complications related to diabetes? It is estimated that between eight and 10 per cent of our overall healthcare expenditure is spent on diabetic complications such as hospitalisation, surgical interventions and long-term wound dressings, etc. Even more concerning is that while other EU countries are successfully reducing the number of diabetes-related amputations by introducing hyperbaric oxygenation (HBOT), Ireland isn't keeping pace.

Hyperbaric oxygenation (HBOT) continues to be a game-changer in treating non-healing wounds, holding FDA approval for various stubborn wound types. OxyGeneration, a clinic supported by Irish Life Health Insurance, has showcased remarkable success stories, including the preservation of limbs due to their HBOT sessions.

Galway-based VERSONO Medical is celebrating the success of a new pilot study which found its FastWire intravascular medical device to be hugely effective at enabling the treatment of the worst type of arterial blockages, reducing amputation in vulnerable patients threatened by sepsis caused by vascular disease.

In Ireland, a nation with approximately 300,000 people living with diabetes, the incidence of amputations among diabetic patients has reached a concerning level.

In Ireland, a nation with approximately 300,000 people living with diabetes, the incidence of amputations among diabetic patients has reached a concerning level. Reports indicate that 671 patients underwent amputations due to diabetic foot ulcers (DFUs) last year, which not only results in life-altering consequences for individuals but also poses a significant economic burden on the healthcare system. These statistics emphasize the importance of implementing this evidence-based treatment to tackle this growing crisis.

Hyperbaric oxygenation is an effective and scientifically proven treatment for non-healing wounds.

Hyperbaric oxygenation is an effective and scientifically proven treatment for non-healing wounds. It works by exposing the person to increased levels of oxygen in a pressurised chamber, which facilitates the healing process. The increased pressure allows more oxygen to enter the bloodstream and reach damaged tissues, therefore promoting wound healing.

Diabetes Ireland urges people with diabetes to be pro-active in looking after their feet and book a foot assessment with a podiatrist as diabetes related amputations remain high despite limited access to healthcare services during Covid times.